Prostatic transrectal ultrasound (TRUS) guided biopsy schemes and TRUS prostatic lesion-guided biopsies

European Urology, Supplement

Volumn 1, Issue 6, 2002, Pages 28-34

  Scattonia, Vincenzo ^a   Zlotta, Alexandre R ^b   Nava, Luciano ^a   Roscigno, Marco ^a   Montorsi, Francesco ^a   Rigatti, Patrizio ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Biopsy; Diagnosis; Prostate cancer; Transrectal ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC PROCEDURE; HUMAN; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

EID: 0036765263     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9056(02)00054-4     Document Type: Article

References (35)

1. Sedelaar M, Vijverberg P, De Reijke T, de la Rosette J, Kil P, Braeckman J, et al. Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives. Eur Urol 2001;40:275-84.
2. Issa MM, Bux S, Chun T, Petros JA, Labadia AJ, Anastasia K, et al. A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: the Emeroy University experience. J Urol 2000;164:397-9.
3. Partin AW. Stutzman RE. Elevated prostate-specific antigen, abnormal prostate evaluation on digital rectal examination and transrectal ultrasound and prostate biopsy. Urol Clin N Am 1998;25:581-9.
4. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-5.
5. Ellis WJ, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol 1994;152:2304-7.
6. Norberg M, Egevad L, Holmberg L, Sparén P, Norlén BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate understimates the presence of cancer. Urology 1997;50:562-6.
7. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1994;151:1571-4.
8. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol 1995;153:1496-8.
9. Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ. Optimization of prostate biopsy strategy using computer based analysis. J Urol 1997;158:2168-75.
10. Melchior SW, Brawer MK. Role of transrectal ultrasound and prostate biopsy. J Clin Ultrasound 1996;24:463-71.
11. Langer JE. The current role of transrectal ultrasonography in the evaluation of prostate carcinoma. Semin Roentgenol 1999;34:284-94.
12. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995:45:2-12.
13. Applewhite JC, Matlaga BR, McCullough DL, Hall CM. Transrectal ultrasound and biopsy in the early diagnosis of prostate cancer. Cancer Control 2001;8:141-50.
14. Presti JCJ, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000;163:163-6.
15. Reitburgen JBW, Kranse R, Kirkels WJ, Hoedemaeker F, Schröder FH. Prostate cancer screening: value of the "seventh" targeted to visible lesions. J Urol 1997;157:58A.
16. 3) hypoechoic lesions in men with normal digital rectal examinations and prostate-specific antigen levels of less than 10 ng/ml. Urology 1999;53:356-8.
17. Gore JL, Shariat SF, Miles BJ, Kadmon D, Jiang N, Wheeler TM, et al. Optimal combinations of systematic and laterally directed biopsies for the detection of prostate cancer. J Urol 2001;165: 1554-9.
18. Werner-Wasik M, Whittington R, Malkowicz SB, Corn BW, Arger, P, Reisinger S, et al. Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate. Urology 1997;50:385-9.
19. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci. Biopsy strategy implications. Cancer 2000;89:1800-9.
20. Djavan B, Zlotta AR, Ekane S, Remzi M, Kramer G, Roumeguère T, et al. Is one set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield. Eur Urol 2000;38:218-24.
21. Terris MK, Pham TQ, Issa MM, Kabalin JN. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 1997; 157:204-6.
22. Fleshner NE, Fair WR. Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 1997;157:556-8.
23. Chang JJ, Shinohara K, Bhargava V, Presti JCJ. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998;160:2111-4.
24. Terris MK, Wallen EM, Stamey TA. Comparison of mid-lobe versus lateral systematic sextant biopsies in the detection of prostate cancer. Urol Int 1997;59:239-42.
25. Aus G, Bergdahl S, Hugosson J, Lodding P, Pihl CG, Pileblad E. Outcome of the laterally directed sextant biopsies of the prostate in screened males aged 50-66 years. Eur Urol 2001;39:655-61.
26. Bauer JJ, Zeng J, Weir J, Zhang W, Sesterhenn IA, Connelly RR, et al. Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology 1999;53:961-7.
27. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163:152-7.
28. Babaian RJ. Extended field prostate biopsy enhances cancer detection. Urology 2000;55:453-6.
29. Toi A, Chen ME, Kamoi K, Troncoso PT, Babaian J. New biopsy strategy detects prostate cancers missed by conventional sextant biopsies. J Urol 1999;161(Suppl):322.
30. Nava L, Montorsi F, Consonni P, Scattoni V, Guazzoni G, Rigatti P. Results of a prospective randomized study comparing 6, 12, 18 transrectal ultrasound guided sextant biopsies in patients with elevated PSA, normal DRE and normal prostatic ultrasound. J Urol 1997;157(Suppl):59A.
31. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-202.
32. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000;164:388-92.
33. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998;159:471-5.
34. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M. Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000;164:393-6.
35. Spencer JA, Alexander AA, Gomella L, Matteucci T, Goldberg BB. Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer. Clin Radiol 1994;49:711-4.